Header Logo

Connection

ALAN SWANN to Phenylcarbamates

Back to Details
This is a "connection" page, showing publications ALAN SWANN has written about Phenylcarbamates.
ALAN SWANN
Connection Strength
0.056
Phenylcarbamates
  1. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ. 2005 Apr 16; 330(7496):874.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.